IndraLab

Statements

Naringin inhibits JUN. 2 / 2
| 2
reach
"Oral administration of naringin reduces the expression and phosphorylation of inhibitor of κB (IκB), IκB kinases (IKKs), p38 mitogen-activated protein kinases (p38 MAPKs), c-Jun N-terminal kinases (JN[MISSING/INVALID CREDENTIALS: limited to 200 char for Elsevier]"
38428704
reach
"In additional experiments, naringin reduced the transcriptional activity of activator protein-1 and nuclear factor kappaB (NF-kappaB), which are two important nuclear transcription factors that are involved in MMP-9 expression."
19810018